Evidence map›Paper›PMID 34964191›Full record

ArticleMolecular microbiology2022

Escherichia coli SymE is a DNA-binding protein that can condense the nucleoid.

Mary K Thompson, Isabel Nocedal, Peter H Culviner, Tong Zhang, Kevin R Gozzi, Michael T Laub

Open access · greenAbstract read
In one paragraph

Article in Molecular microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Mary K ThompsonDepartment of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Isabel NocedalHoward Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Peter H CulvinerDepartment of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Tong ZhangDepartment of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.ORCID 0000-0003-4745-8580
Kevin R GozziDepartment of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
Michael T LaubDepartment of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.ORCID 0000-0002-8288-7607
Massachusetts Institute of Technology · USHoward Hughes Medical Institute · US

Funding

Cell Cycle Regulation in Caulobacter CrescentusR01GM082899 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI LAUB, MICHAEL · 2008 to 2020
$3.8M
Howard Hughes Medical InstituteNIGMS NIH HHS R01 GM082899
6 · The paper itself

Abstract

Type I toxin-antitoxin (TA) systems typically consist of a protein toxin that imbeds in the inner membrane where it can oligomerize and form pores that change membrane permeability, and an RNA antitoxin that interacts directly with toxin mRNA to inhibit its translation. In Escherichia coli, symE/symR is annotated as a type I TA system with a non-canonical toxin. SymE was initially suggested to be an endoribonuclease, but has predicted structural similarity to DNA binding proteins. To better understand SymE function, we used RNA-seq to examine cells ectopically producing it. Although SymE drives major changes in gene expression, we do not find strong evidence of endoribonucleolytic activity. Instead, our biochemical and cell biological studies indicate that SymE binds DNA. We demonstrate that the toxicity of symE overexpression likely stems from its ability to drive severe nucleoid condensation, which disrupts DNA and RNA synthesis and leads to DNA damage, similar to the effects of overproducing the nucleoid-associated protein H-NS. Collectively, our results suggest that SymE represents a new class of nucleoid-associated proteins that is widely distributed in bacteria.

Indexed as

AntitoxinsEscherichia coli ProteinsBacterial ProteinsDNA-Binding ProteinsEscherichia coliRNA, MessengerAntitoxinsBacterial ProteinsDNA-Binding ProteinsEscherichia coli ProteinsRNA, MessengerDNA-binding proteinEscherichia colinucleoid-associated proteinSymE

Identifiers

PMID34964191
PMCPMC9018529
OpenAlexW4200516851

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.